Bardees M Foda

6PUBLICATIONS
21CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsGene expression (incl. microarray and other genome-wide approaches)Supramolecular chemistry
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 07, 2026
Both soluble and cell surface CD137 expressed by Foxp3+ CD4 T cells restrain autoimmune diabetes.

|Jun 20, 2024
Inhibition of the Rho/MRTF pathway improves the response of BRAF-resistant melanoma to PD1/PDL1 blockade.

Bardees M Foda, Sean A Misek, Kathleen A Gallo

|Sep 28, 2023
Role of Rho/MRTF in Aggressive Vemurafenib-Resistant Murine Melanomas and Immune Checkpoint Upregulation.

Bardees M Foda, Richard R Neubig

|Dec 19, 2022
ILEE: Algorithms and toolbox for unguided and accurate quantitative analysis of cytoskeletal images.

Pai Li, Ze Zhang, Yiying Tong

|May 14, 2020
Mutational analysis of Aurora kinase C gene in Egyptian patients with macrozoospermia.

Maha M Kobesiy, Bardees M Foda, Ola S M Ali

|Apr 17, 2020
The CD137 Ligand Is Important for Type 1 Diabetes Development but Dispensable for the Homeostasis of Disease-Suppressive CD137+ FOXP3+ Regulatory CD4 T Cells.

Bardees M Foda, Ashley E Ciecko, David V Serreze

Pageof 1

Frequent Collaborators

2 joint publications

Richard R Neubig

1 joint publications

David V Serreze

1 joint publications

Maha M Kobesiy

1 joint publications

Ola S M Ali